When depression has not improved enough with medication, therapy, or both, the question is rarely just, “What treatment should I try next?” It is often, “What fits my symptoms, medical history, schedule, and life?” Comparing TMS vs ketamine treatment can help clarify two advanced options, but the right answer depends on a comprehensive assessment rather than a one-size-fits-all recommendation.

Both treatments may be considered for treatment-resistant depression and certain related mental health concerns. They work differently, require different levels of monitoring, and may fit different clinical situations. For people also managing chronic pain, trauma symptoms, anxiety, fatigue, substance use concerns, or medication side effects, the decision becomes even more individualized.

TMS vs Ketamine Treatment: The Core Difference

Transcranial magnetic stimulation, or TMS, uses targeted magnetic pulses to stimulate specific brain regions involved in mood regulation. It is a noninvasive, office-based treatment that does not require anesthesia or sedation. A patient remains awake and can typically return to work, drive, or continue normal activities after an appointment.

Ketamine treatment uses a medication that affects glutamate signaling and may produce rapid changes in mood for some patients. Ketamine may be delivered through several routes, including IV infusion, while esketamine nasal spray, commonly known by the brand name Spravato, is an FDA-approved medication for specific forms of treatment-resistant depression and must be administered under supervised clinical protocols. Traditional racemic ketamine is commonly used off label in psychiatric care.

In practical terms, TMS is a series-based brain stimulation treatment delivered over several weeks. Ketamine-based care is a medication treatment that may have a faster perceived onset but requires observation during and after administration because of temporary changes in perception, blood pressure, coordination, and alertness.

How TMS Works and Who May Benefit

TMS treatment is commonly used for major depressive disorder, particularly when antidepressant medications have not provided adequate relief or have caused difficult side effects. Depending on the protocol and clinical indication, TMS may also be considered for conditions such as obsessive-compulsive disorder. A psychiatric provider determines whether a patient is an appropriate candidate.

During a TMS session, a small treatment coil rests against the scalp. The device delivers magnetic pulses that activate targeted nerve circuits. Initial visits include careful mapping to identify the treatment location and determine the appropriate dose. Sessions often last roughly 20 to 40 minutes, although exact timing varies by protocol.

A standard course usually involves frequent appointments, often five days per week for several weeks, followed by possible taper sessions. That schedule can be a meaningful commitment, especially for people who work full time, travel, or have limited transportation. On the other hand, patients value that TMS does not involve an infusion, sedation, or a recovery period after each session.

The most common side effects are scalp discomfort or headache during or shortly after treatment. Serious risks are uncommon, but seizure risk must be reviewed, especially for people with a seizure history or certain neurological conditions. TMS may not be appropriate for everyone with metal or electronic implants near the head, so screening matters.

Improvement with TMS is usually gradual. Some people notice shifts in sleep, motivation, emotional resilience, or daily functioning before they feel a full change in mood. Others need time to determine whether the treatment is helping. This makes consistent symptom tracking and ongoing provider communication especially useful.

How Ketamine and Esketamine Care Differ

Ketamine’s mechanism is different from conventional antidepressants. Rather than primarily acting on serotonin or norepinephrine pathways, it influences glutamate-related signaling. For some appropriately screened patients, this can create relief from depressive symptoms more quickly than traditional medications. A rapid response is possible, but it is not guaranteed, and it should not be mistaken for a permanent solution after a single treatment.

During ketamine treatment, patients are monitored in a clinical setting. Temporary dissociation, dizziness, nausea, sedation, elevated blood pressure, or changes in perception can occur. Patients need a safe ride home and should plan for recovery time rather than returning immediately to work or driving.

Esketamine nasal spray follows a structured in-office monitoring model. It is prescribed under specific safety requirements and is generally used alongside an oral antidepressant for approved indications. The treatment schedule is often more frequent at the beginning and then adjusted based on response and the ongoing care plan.

Ketamine-based treatment may be considered when depression is severe, persistent, or accompanied by urgent functional decline, provided the patient is clinically appropriate. It can also be relevant when a person needs a treatment approach that does not require daily appointments over several weeks. However, a history of uncontrolled high blood pressure, certain cardiovascular conditions, psychosis, dissociation, or active substance misuse may change the risk-benefit discussion.

Choosing Between TMS and Ketamine

The question is not whether TMS or ketamine is universally “better.” It is which approach makes clinical sense for the person in front of the provider. A thoughtful plan considers diagnosis, symptom severity, past treatment response, medication tolerance, safety factors, scheduling realities, and personal preferences.

TMS may be a strong fit for someone seeking a non-medication, nonsedating intervention who can attend regular appointments and prefers a gradual, structured course of care. It may also appeal to someone concerned about systemic medication effects or who has experienced limited benefit from antidepressants.

Ketamine or esketamine care may be worth discussing when speed of response is a major concern, when prior medication trials have been unsuccessful, or when monitored medication treatment better matches the patient’s needs. It requires comfort with the treatment experience itself, including temporary altered perception and a longer observation period on treatment days.

Cost and coverage can also affect the decision. Insurance coverage for TMS and Spravato may be available when clinical criteria are met, while IV ketamine coverage varies widely. Before beginning treatment, patients should understand expected visit frequency, authorization requirements, out-of-pocket costs, and the maintenance plan if symptoms return.

Why Coordinated Care Changes the Conversation

Depression rarely exists in isolation. Sleep disruption, chronic pain, hormonal changes, trauma, inflammatory conditions, alcohol or substance use, burnout, nutritional factors, and medication effects can all influence mood and treatment response. Treating depression without evaluating these root contributors can leave part of the picture unaddressed.

A coordinated strategy may include psychiatric evaluation, psychotherapy, medication management, and attention to physical contributors such as pain, mobility limitations, fatigue, metabolic health, or hormone concerns. Therapy remains valuable with either TMS or ketamine treatment. It can help patients process changes, build coping skills, address trauma patterns, and create sustainable routines as symptoms improve.

At Quad Cities Integrative Wellness, this whole-person perspective helps connect mental health care with related concerns that may be affecting recovery. Shared assessment and communication across services can reduce the fragmentation that often leaves patients repeating their history while trying to piece together separate recommendations.

Questions to Bring to Your Consultation

A productive consultation should go beyond asking whether you qualify for TMS or ketamine. Ask what diagnosis is being treated, what other options have already been tried, how progress will be measured, and what happens if the first approach does not provide enough relief. Discuss your full medication list, medical conditions, substance use history, sleep patterns, trauma history, and practical limits around transportation, work, and caregiving.

You should also ask how the treatment will fit with therapy and existing psychiatric medications. In some cases, TMS, ketamine-based care, medication changes, and therapy are considered at different points in the same longer-term plan. The goal is not to chase the newest intervention. It is to build a plan that is safe, clinically sound, and realistic enough to follow through.

If depression is affecting your ability to function, connect with a qualified mental health provider for a comprehensive assessment. And if you are experiencing thoughts of self-harm or cannot stay safe, seek immediate emergency support or call or text 988. The most helpful next step is often a careful conversation that treats your symptoms, health history, and goals as connected parts of the same recovery path.